What is endocannabinoid system (ECS)?
The endocannabinoid system (ECS) is a complex network of receptors and neurotransmitters that is involved in regulating various physiological processes in the body, such as mood, appetite, pain sensation, immune function, and sleep. It was discovered in the 1990s by researchers who were studying the effects of THC, the main psychoactive compound in cannabis, on the body.
The ECS is made up of three main components: endocannabinoids, receptors, and enzymes. Endocannabinoids are naturally occurring compounds that are produced by the body and act as signaling molecules, similar to neurotransmitters. Receptors are proteins that are found on the surface of cells and are responsible for receiving signals from endocannabinoids. Enzymes are responsible for breaking down endocannabinoids once they have fulfilled their signaling role.
There are two main types of receptors in the ECS: CB1 receptors, which are primarily found in the brain and central nervous system, and CB2 receptors, which are primarily found in the immune system and peripheral tissues. Endocannabinoids bind to these receptors and activate various signaling pathways, which can have a range of effects on the body.
The discovery of the ECS has led to a greater understanding of how cannabinoids, such as THC and CBD, affect the body, and has opened up new avenues for research into the therapeutic potential of these compounds.